Introduction
============

Lycopene is a C40 isoprenoid compound in the carotenoid family. Due to its anti-oxidative and anti-cancer activities ([@B63]; [@B24]), lycopene has been widely used for nutritional supplements, pharmaceutical and cosmetic products ([@B75]). The conventional methods for lycopene production include direct extraction from plants,chemical synthesis and microbial fermentation. Among these methods, microbial production of lycopene is more economical and sustainable ([@B14]). Recently, with the development of metabolic engineering techniques and synthetic biology, lycopene overproduction has been realized in *Escherichia coli* ([@B83]; [@B75]; [@B77]; [@B80]), yeast ([@B78]; [@B62]), *Blakeslea trispora* ([@B40]; [@B73], [@B74]), and *Rhodobacter sphaeroides* ([@B68]). However, the field is seeking a better platform for large-scale production of lycopene or other carotenoids. Halophilic archaea (haloarchaea) belong to the domain Archaea and are unique microorganisms that survive under the high salt condition ([@B65]). Many haloarchaeal species are capable of producing the compounds of the carotenoid family ([@B60]), such as phytoene, β-carotene, lycopene, as well as the derivatives of bacterioruberin and salinixanthin ([@B18]). Particularly, they hold several advantages for carotenoid production: the high-salt tolerance enables haloarchaea cultivation under non-sterile condition and thus reduces the energy cost ([@B65]). Additionally, the process of carotenoid extraction from haloarchaea is relatively simple, as the cell lysis undergoes in low sodium chloride (NaCl) condition. Consequently, haloarchaea are considered as an alternative producer for carotenoids ([@B49]).

*Haloferax mediterranei* can use probably the largest range of single carbon sources and grows faster than other known members of the *Halobacteriaceae* ([@B51]). Its complete genome information is available ([@B31]), and the *pyrF*-based gene knockout system for genome-wide manipulation has also been well-established in this strain ([@B39]). With these merits, *H. mediterranei* has been one of the most common model strains for the study of physiology and metabolism in archaea. For example, it has been used to investigate poly(3-hydroxybutyrate-*co*-3-hydroxyvalerate) (PHBV) biosynthesis and its metabolism regulation processes ([@B28], [@B30]; [@B82]; [@B8]; [@B11]). However, only a few studies on its carotenoid production has been reported till recently. [@B21] improved the C50 carotenoid production to 0.604 A~494~ ~nm~/mL broth *via* a two-stage cultivation approach. [@B13] used extruded rice bran and starch under optimal conductivity of brined medium for a high red pigment production of 556 mg/L. However, there is no work investigating either the production of other carotenoids (e.g., lycopene), or the pathway engineering to improve carotenoid production in *H. mediterranei*.

In this study, we explored the possibility to use *H. mediterranei* as a potential cell factory for lycopene production by multiple strategies (Figure [1](#F1){ref-type="fig"}). First, we attempted to identify and eliminate the rate-limiting steps involved in lycopene biosynthesis. Then we disrupted bacterioruberin synthesis to increase lycopene accumulation and purity. Heterologous phytoene synthase (CrtB) and phytoene desaturase (CrtI) encoding genes from other haloarchaea were employed for further enhancing lycopene production. Subsequently, we blocked PHBV synthesis to divert more acetyl-CoA flux to lycopene synthesis and also complemented the *pyrF* gene in the engineered strain for its future application in industrial scale. We finally obtained a metabolic engineered *H. mediterranei* strain with relatively high purity and production of lycopene.

![Schematic illustration of engineered *H. mediterranei* for lycopene production. **(A)** Enhancement of lycopene synthesis by enhancing lycopene biosynthetic pathway and blocking its flux to bacterioruberin and its competitive pathway for PHBV biosynthesis. Green arrows represent enhanced steps and red arrows and crosses represent blocked steps. **(B)** Flowchart of engineering *H. mediterranei* strain for increasing lycopene synthesis. Green terms represent gene insertion and red ones represent gene deletion. The blue terms show the plasmids used for constructing the mutants of *H. mediterranei*.](fmicb-09-02893-g001){#F1}

Materials and Methods {#s1}
=====================

Strains, Medium, and Culture Conditions
---------------------------------------

All the strains used in this study are listed in Supplementary Table [S1](#SM1){ref-type="supplementary-material"}. *E. coli* JM109 ([@B61]) was used for plasmids construction and *E. coli* JM110 was used to eliminate the methylated plasmid *in vivo* ([@B52]). Luria Broth (LB) medium was used for *E. coli* culture at 37°C. When needed, 100 μg/mL of ampicillin was added to LB medium. *H. mediterranei* was cultivated at 37°C in nutrient-rich AS-168 medium (per liter, 5 g casamino acids, 5 g yeast extract, 1 g sodium glutamate, 3 g trisodium citrate, 2 g KCl, 20 g MgSO~4~ ⋅ 7H~2~O, 200 g NaCl, 5 mg FeSO~4~ ⋅ 7H~2~O, and 0.036 mg MnCl~2~ ⋅ 4H~2~O \[pH 7.0\]). AS-168SY medium was similar to AS-168 medium, except that yeast extract was excluded. Plasmids were transformed into *H. mediterranei* with the polyethylene glycol-mediated transformation method ([@B16]). When required, AS-168 medium was supplemented with 50 mg/mL uracil (Sangon, China) and 250 mg/mL 5-Fluoroorotic acid (Sangon, China) for counter-selection of the recombinants without *pyrF* marker. For lycopene production, a 1% (V/V) seed culture of *H. mediterranei* or its mutants was inoculated into a shake flask containing 50 mL of MG medium (per liter, 110 g NaCl, 20.51 g MgCl~2~, 29.52 g MgSO~4~, 5 g KCl, 1 g CaCl~2~, 2 g NH~4~Cl, 0.0375 g KH~2~PO~4~, 10 g glucose, 15 g PIPES, Fe(III) citrate, and 1 mL trace element solution SL-6 \[pH 7.2\]) ([@B5]) and cultured at 37°C and 200 rpm for 7 days.

Plasmid Construction for Gene Overexpression
--------------------------------------------

The native candidate genes involved in lycopene synthesis were amplified with primers listed in Supplementary Table [S2](#SM1){ref-type="supplementary-material"} from the *H. mediterranei* genomic DNA. The heterologous *crt* genes *HAH_2563* (*crtB*~ha~), *HAH_1058* (*crtI*~ha~) and *OE_3093R* (*crtB*~hs~), *OE_3381R* (*crtI*~hs~) were obtained *via* PCR from the genomic DNA of *Haloarcula hispanica* and *Halobacterium salinarum*, respectively. Amplified fragments were inserted into pWLR \[derived from pWL502 by insertion of a strong promoter P~phaR~ ([@B10])\] digested with BamHI and XbaI, by using One Step Cloning Kit (Yeasen, Co., Ltd., China), to generate plasmids for gene overexpression under the control of promoter P~phaR~ (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}).

Plasmid Construction for Gene Integration in Chromosome
-------------------------------------------------------

All plasmids for gene knock-in or knock-out were constructed based on a suicide plasmid pHFX ([@B39]). A 583-bp DNA fragment located immediately upstream of *crtB*~hm~ was amplified with primer pair *crtB*-in-1/*crtB*-in-2 from *H. mediterranei* genomic DNA. Another 580-bp fragment containing promoter P~phaR~ and the partial 5′ region of *crtB* was amplified with primer pair *crtB*-in-3/*crtB*-in-4 from plasmid pW2547 used for *crtB*~hm~ overexpression (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Then, the two PCR products were inserted into the plasmid pHFX to construct the integration plasmid of pHFXB, which was used to replace the native promoter of *HFX_2547 (crtB*~hm~) in chromosome. For the heterologous *crt* gene integration, a 524-bp fragment up-stream of *HFX_2549* and a 529-bp fragment down-stream of *HFX_2549* were amplified by relevant primer pairs (Supplementary Table [S2](#SM1){ref-type="supplementary-material"}). Different *crt* gene fragments containing P~phaR~ were amplified by using *crtB*~ha~, *crtI*~ha~, *crtB*~hs~, and *crtI*~hs~ overexpression plasmids pWHA2563, pWHA1058, pWOE3093, and pWOE3381 (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}) as PCR template, respectively. The corresponding homologous arm fragments and different *crt* genes, containing promoter P~phaR~, were assembled into pHFX to construct plasmids containing different *crt* genes used for their integration in chromosome (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"} and Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). Similar to the plasmid construction method as described above, primer pairs *HFX_2549*-K1/*HFX_2549*-K2 and *HFX_2549*-K3/*HFX_2549*-K4 were used to construct the plasmid pHFX2549K for *HFX_2549* knock-out. Primer pairs *phaEC*-K1/*phaEC*-K1 and *phaEC*-K3/*phaEC*-K4 were used for the construction of pHFXPK for *phaEC* knock-out (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}).

Analysis of Carotenoids by Thin Layer Chromatography (TLC)
----------------------------------------------------------

Carotenoids in acetone extract obtained from different cultures were analyzed by thin layer chromatography (TLC), following the protocol described by [@B67] with slight modifications. Briefly, after cultivation in MG medium for 7 days, the cells (1 mL) were harvested by centrifugation (12,000 × *g* for 5 min, at 4°C), and resuspended in acetone (1 mL) under a reduced light condition to prevent photo-bleaching and degradation ([@B2]). The acetone supernatant containing carotenoids was collected and transferred to a new tube. This process was repeated until the pellets were totally white. Acetone extracted carotenoids (10 μL) were analyzed by TLC on a silica plate (GF254, Qingdao Haiyang Chemical, Co., Ltd., China) with acetone and n-heptane (1:1, v/v) as the development liquid in fume hood at room temperature. In addition, the visualized spot on the resulting TLC plate was scraped off, and extracted with 200 μL of acetone. The obtained supernatant was then scanned under 350--550 nm.

Lycopene Quantification
-----------------------

The lycopene content in the extract was determined by using a HPLC system (Agilent, 1260, United States) equipped with a ZORBAX Eclipse XDB-C18 column (4.6 mm × 150 mm, 5 μm) and a UV/VIS detector. The absorption was detected at 450 nm. The mobile phase consisted of methanol-isopropanol (65:35 V/V) with a flow rate of 1 mL/min at 30°C. Injection volume of sample was 20 μL. The lycopene concentration was calculated based on the calibration curve of lycopene (Macklin Biochemical, Co., Ltd., China).

PHA Content Analysis
--------------------

The cells were collected by centrifugation at 10,000 × *g*, 4°C, 15 min and lyophilized. The lyophilized cells were treated with a mixture of chloroform and methanol containing 3% (v/v) sulfuric acid at 95°C for 4 h. The resulting hydroxyacyl methylesters were then analyzed by GC-6820 instrument (Agilent, United States) as described by [@B29].

RNA Extraction and Quantitative Reverse Transcription-PCR (qRT-PCR)
-------------------------------------------------------------------

The cells were cultured in AS-168 medium at 37°C for 12 h and subsequently harvested by centrifugation (12,000 × *g*, 4°C). The total RNA was extracted using TRIzol reagent (Invitrogen, United States) as previously described ([@B42]). TURBO DNA-free^TM^ Kit (Thermo Fisher Scientific, United States) was used for removing DNA contamination. The cDNA was synthesized by reverse transcription with random hexamer primers from 1 μg of DNA-free total RNA using the Moloney Murine Leukemia Virus Reverse Transcriptase (M MLV-RT) (Promega, United States). The relative fold of gene expression was analyzed by ViiA^TM^ 7 Real-Time PCR System (Applied Biosystems, Inc., United States), using 7S RNA as an endogenous control to normalize the data of each sample. The primers used are listed in Supplementary Table [S2](#SM1){ref-type="supplementary-material"}.

Sequences Analysis and Databases
--------------------------------

The DNA sequences were obtained from National Center for Biotechnology Information (NCBI) Genome Database. The information about the most identified enzymes involved in MVA and lycopene synthesis pathway (supported by evidence at protein level), was accessed from UniProt Database^[1](#fn01){ref-type="fn"}^. Sequence homology was assessed by BLASTN or BLASTP in NCBI ([@B3]). Predictions of transmembrane helices in the proteins were performed by using the TMHMM Server v2.0^[2](#fn02){ref-type="fn"}^ ([@B37]).

The genome accession numbers deposited in GenBank are as following, *H. mediterranei* ([CP001868.2](CP001868.2)), *H. hispanica* ([NC_015948.1](NC_015948.1)), and *H. salinarum* ([AM774415.1](AM774415.1)).

Statistical Analysis
--------------------

Experiments were performed in triplicate and data was analyzed by the GraphPad Prism 7 software and represented as mean ± standard deviation. Statistical analysis was done using a two-tailed *t*-test. Statistical significance was defined as ^∗^*p* \< 0.05.

Results
=======

Identifying the Rate-Limiting Steps Involved in Native Lycopene Biosynthesis
----------------------------------------------------------------------------

*In silico* metabolic pathway analysis reveals that *H. mediterranei* has a complete lycopene biosynthetic pathway, referring to the steps from isopentenyl-PP (IPP) and dimethylallyl-PP (DMAPP) to lycopene (Figure [2](#F2){ref-type="fig"}). Mevalonate (MVA) pathway provides the two important precursors, IPP and DMAPP, for lycopene synthesis. In MVA pathway, two molecules of acetyl-CoA are condensed to form acetoacetyl-CoA and a third acetyl-CoA molecule is then added to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) by Hydroxymethylglutaryl-CoA synthase (MvaB, HFX_2424). The next step involves the conversion of HMG-CoA to MVA by Hydroxymethylglutaryl-CoA reductase (HmgR, HFX_2609). MVA is then phosphorylated by Mevalonate kinase (Erg12, HFX_2773) to generate mevalonate phosphate (MVAP). Different from the classical MVA pathway, an alternative pathway is proposed for the IPP generation from MVAP, which is catalyzed by Diphosphomevalonate decarboxylase (DmD, HFX_1486) and Isopentenyl phosphate kinase (IpK, HFX_2774). IPP can be then isomerized to DMAPP by Isopentenyl-diphosphate delta-isomerase (IdI, HFX_2519). DMAPP and IPP are condensed to geranyl-PP (GPP) and then to farnesyl-PP (FPP) and finally to geranylgeranyl-PP (GGPP) by trifunctional prenyl diphosphate synthase (IdsA, HFX_2735). Two molecules of GGPPs are condensed by CrtB (HFX_2547) to form phytoene and then it undergoes four consecutive desaturation reactions catalyzed by CrtI (HFX_2550) to produce lycopene.

![Proposed main steps in the mevalonate and lycopene biosynthesis pathways of *H. mediterranei* based on the KEGG pathway database. For simplicity, cofactors and ATP consumption are not shown. Gray arrows show the MVA pathway and black ones show the lycopene biosynthetic pathway descripted in this study.](fmicb-09-02893-g002){#F2}

Although *H. mediterranei* possessed the complete lycopene synthetic pathway, we could not detect lycopene accumulation in this strain (Figure [3B](#F3){ref-type="fig"}). The extremely low lycopene production might be due to the rate-limiting steps in its lycopene biosynthesis. According to the previous studies about rate-limiting steps in MVA and lycopene synthesis pathway ([@B26]; [@B34]; [@B66]; [@B4]; [@B41]; [@B7]), we selected all the predicted genes as our candidates to be overexpressed in *H. mediterranei* (Figure [2](#F2){ref-type="fig"} and Table [1](#T1){ref-type="table"}). To rapidly identify the rate-limiting steps, we used a plasmid-based expression system for candidate genes overexpression under the control of a strong constitutive promoter P~phaR~. The expression plasmid containing each gene was transformed into the strain DF50Δeps ([@B82]) individually and correct transformants were confirmed by PCR and Sanger sequencing. Functional overexpression of the genes encoding rate-limiting enzymes made transformants orange or even red, so it was easy to identify the genes encoding rate-limiting enzymes. Obviously, only the overexpression of gene *crtB*~hm~ resulted in an orange colored phenotype (Figure [3A](#F3){ref-type="fig"}). Meanwhile the lycopene accumulation in this *crtB*~hm~-overexpressed strain DF50-2547 was further confirmed by HPLC (Figure [3B](#F3){ref-type="fig"}), whereas no lycopene accumulation was detected in other gene overexpressed strains (Supplementary Figure [S2](#SM1){ref-type="supplementary-material"}). These results indicated that the step from GGPP to phytoene was the rate-limiting step in lycopene synthesis in *H. mediterranei*.

![Identification of the rate-limiting steps involved in lycopene biosynthesis in *H. mediterranei*. **(A)** Collected *H. mediterranei* cells (1 mL) with a single gene overexpressed in eppendorf tubes. *HFX_2773* and *HFX_2774* are overlapped by four nucleotides and thus they are co-expressed. **(B)** HPLC analysis of the lycopene produced by DF50-2547 and DF50Δeps. **(C)** qRT-PCR analysis of *crtB*~hm~ transcriptional level in DF50Δeps and 50crtB. The relative fold of *crtB*~hm~ gene expression level is calculated by normalization to the expression of inner control 7S RNA. Insets are the photographs of 7-day shake flask cultures.](fmicb-09-02893-g003){#F3}

###### 

Identity analysis between candidate enzymes involved in lycopene biosynthesis in *H. mediterranei* and idendified enzymes.

  Enzyme in *H. mediterranei*   Identified enzymes   Protein identity                                        
  ----------------------------- -------------------- ------------------ ------------------------------------ -----
  MvaB                          *HFX_2424*           *HVO_2419*         *H. vocanii* ([@B71])                95%
  HmgR                          *HFX_2609*           *HVO_2583*         *H. vocanii* ([@B9])                 89%
  Erg12                         *HFX_2773*           *HVO_2761*         *H. vocanii* ([@B6])                 92%
  DmD                           *HFX_1486*           *HVO_1412*         *H. vocanii* ([@B70])                90%
  IpK                           *HFX_2774*           *HVO_2762*         *H. vocanii* ([@B70])                89%
  IdI                           *HFX_2519*           *idi*              *E. coli* ([@B32])                   32%
  IdsA                          *HFX_2735*           *ispA*             *E. coli* ([@B33])                   31%
                                                     *crtE*             *E. vulneris*                        30%
  CrtB                          *HFX_2547*           *crtB*             *Synechococcus elongatus* ([@B12])   32%
  CrtI                          *HFX_2550*           *crtI*             *Erwinia uredovora* ([@B22])         31%

Reinforcing the Rate-Limiting Step in Lycopene Synthesis by Insertion of a Strong Promoter
------------------------------------------------------------------------------------------

The plasmid-based overexpression of *crtB*~hm~ could reinforce the rate-limiting step and thus enhanced the production of lycopene in *H. mediterranei*. However, this plasmid-based system is not genetically stable and probably brings a metabolic burden. To address this issue, we therefore constructed the plasmid pHFXB (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}) and used a two-step homologous recombination method to insert promoter P~phaR~ into the chromosome immediately up-stream of *crtB*~hm~ in DF50Δeps. The engineered strain, termed 50crtB, was easy to be distinguished visually, because of its orange color, which was different from the light pink color of its parental strain DF50Δeps (Figure [3C](#F3){ref-type="fig"}).

Next, we analyzed the transcription level of *crtB*~hm~ in strain 50crtB and DF50Δeps by qRT-PCR. The result showed that the insertion of promoter P~phaR~ dramatically increased the transcription level of *crtB*~hm~ by 245 times, when compared with the DF50Δeps strain (Figure [3C](#F3){ref-type="fig"}). As expected, the high CrtB~hm~ expression level significantly promoted the conversion from GGPP to phytoene and subsequently improved lycopene biosynthesis. After cultivation in shake flasks containing 50 mL MG medium for 7 days, a lycopene production of 6.05 ± 0.18 mg/g dry cell weight (DCW) (35.15 ± 0.43 mg/L) was achieved (Figure [4C](#F4){ref-type="fig"}).

![Analysis of lycopene production of 50crtB and 50BΔ2549. **(A)** TLC analysis of the carotenoids extracted from 50crtB and 50BΔ2549. Spot 1 contains mainly lycopene, Spot 2--Spot 4 consists of bacterioruberin and its derivates. **(B)** UV-Vis absorption spectra of the carotenoids extracted from the pigment spot of 50BΔ2549 in TLC plate. The wavelength range is set as 350 ∼ 550 nm. **(C)** Lycopene titer and production of 50crtB and 50BΔ2549. Strains are cultured for 7 days in 50 mL MG medium at 37°C in shake flasks. *^∗^p* \< 0.05, lycopene production and titer of the group 50BΔ2549 are compared with the 50crtB. Data is expressed as Mean ± SD of triplicate determinations.](fmicb-09-02893-g004){#F4}

Disrupting Bacterioruberin Biosynthesis to Improve the Accumulation and Purity of Lycopene
------------------------------------------------------------------------------------------

Lycopene is the last shared intermediate in bacterioruberin and retinal biosynthesis in some haloarchaea ([@B56]). However, *H. mediterranei* lacks the genes, *crtY* (encoding lycopene cyclase) ([@B55]), *brp* and *blh* (encoding β-carotene dioxygenase) ([@B54]), involved in the retinal biosynthesis pathway and therefore, lycopene can only flux into bacterioruberin biosynthesis (Figure [1A](#F1){ref-type="fig"}). Thus, we next blocked bacterioruberin biosynthesis to enhance lycopene accumulation and its purity. Bioinformatic analysis revealed the presence of two genes (*HFX_1501* and *HFX_2549*) potentially involved in bacterioruberin synthesis in *H. mediterranei*. Both of them are annotated as putative prenyltransferases, which can transfer 5-carbon prenyl groups to various substrates. *HFX_1501* encodes a protein of 284 amino acid residues, which showed 30 and 28% identity to the LyeJ of *H. salinarum* and *H. japonica*, respectively (Supplementary Figure [S3A](#SM1){ref-type="supplementary-material"}). In the case of *HFX_2549*, it encodes a 292-amino acid protein exhibiting 64 and 61% identity to the LyeJ of *H. salinarum* and *H. japonica*, respectively (Supplementary Figure [S3B](#SM1){ref-type="supplementary-material"}). Moreover, it is located within the carotenoid biosynthetic gene cluster. Furthermore, a membrane topology analysis using TMHMM revealed that *HFX_2549* encoded an integral membrane protein containing seven transmembrane domains (Supplementary Figure [S3B](#SM1){ref-type="supplementary-material"}), consistent with the LyeJ of *H. salinarum* or *H. japonica*. This suggested that *HFX_2549* is likely to encode LyeJ in *H. mediterranei.*

We knocked out the gene, *HFX_2549*, and obtained the strain 50BΔ2549. The carotenoid components of the 50crtB and 50BΔ2549 strains were analyzed qualitatively by TLC. The sample from 50crtB displayed multiple spots on the silica plate (Figure [4A](#F4){ref-type="fig"}, Spots 1--4), which represented lycopene, bacterioruberin and its derivates. In contrast, the sample from 50BΔ2549 only contained a single spot 1 (Figure [4A](#F4){ref-type="fig"}, Spot 1). Subsequently, spot 1 on the silica plate from the 50BΔ2549 strain was recovered and extracted by using acetone. The UV-Vis absorbance spectrum of the extracted sample had a typical three-finger shape of lycopene at 442, 470 and 501 nm, similar to the absorption spectrum of lycopene standard (Figure [4B](#F4){ref-type="fig"}). These results indicated that 50BΔ2549 could not synthesize bacterioruberin and its derivates, and the reaction was terminated at the lycopene step. Consequently, HFX_2549 was the key enzyme for bacterioruberin synthesis in *H. mediterranei*. Lycopene production of 50BΔ2549 was further quantified by HPLC. The production significantly increased to 45.54 ± 1.23 mg/g DCW, which was about 6.5 times higher than that of 50crtB (Figure [4C](#F4){ref-type="fig"}).

Lycopene Production Improvement by Importing Phytoene Desaturase From Other Haloarchaea
---------------------------------------------------------------------------------------

To improve the yield of the target products, it is often necessary to enhance the availability of essential precursors ([@B78]). In our study, overexpression of *crtB*~hm~ supplied more precursor, phytoene, for lycopene synthesis, and enhancement of the flux from phytoene to lycopene is another strategy for lycopene production improvement. Here, we strengthened the process by importing heterologous gene *crtI*~ha~ or *crtI*~hs~ from carotenogenic haloarchaea, *H. hispanica* or *H. salinarum*. First, we confirmed the function of *crtI*~ha~ and *crtI*~hs~ by transforming their expression plasmid pWHA1058 or pWOE3381 (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}) into the 50BΔ2549 strain. The positive transformants with the functional expression of heterologous *crtI* showed enhanced color intensity (Figure [5A](#F5){ref-type="fig"}). Afterward, we constructed two plasmids, pHI6 and pHIH (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}), for the integration of *crtI*~ha~ and *crtI*~hs~ into the chromosome of *H. mediterranei* (Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}). To avoid unpredictable effects brought by the insertion site, we used 50crtB as the host and integrated these two genes separately in the chromosome by replacing *HFX_2549* (Figure [1B](#F1){ref-type="fig"}). The two resultant strains were named 50BI6 and 50BIH (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}).

![Importation of heterologous *crt* genes to improve lycopene production. **(A)** Colony color of *H. mediterranei* 50BΔ2549 cultured in AS-168 medium and the strains after introducing the expression plasmid containing *crtI* from *Haloarcula hispanica* or *Halobacterium salinarum* cultured in AS-168Y medium. 50BΔ2549 with pWHA1058 means *crtI*~ha~ expressed strain and pWOE3381 means *crtI*~hs~ expressed strain. **(B)** *crtB-crtI* expression cassettes. Each gene was under the control of P~phaR~ promoter and a terminator was in the downstream of *crtB*~ha~ or *crtB*~hs~. **(C)** Lycopene titer and production of engineered *H. mediterranei* by insertion of heterologous *crt* genes in the chromosome of 50crtB by replacing *HFX_2549*. Strains are cultured for 7 days in 50 mL MG medium at 37°C in shake flasks.](fmicb-09-02893-g005){#F5}

Lycopene production by the engineered strains were then determined by HPLC. Lycopene yields of 56.46 ± 0.74 mg/g DCW (292.21 ± 2.88 mg/L) and 49.37 ± 2.95 mg/g DCW (271.43 ± 6.07 mg/L) were obtained in the engineered strains, 50BI6 and 50BIH, respectively. This result showed that the heterologous expression of *crtI*~ha~ in *H. mediterranei* was more effective for enhancing lycopene synthesis compared to *crtI*~hs~. Finally, 50BI6 got a 24.0% increase in lycopene production and 10.2% increase in lycopene titer compared to 50BΔ2549 (Figure [5C](#F5){ref-type="fig"}).

Heterologous *crtB* Overexpression for Further Optimizing Lycopene Production
-----------------------------------------------------------------------------

The high lycopene production strain 50BI6 contained two copies of *crtI* (*crtI*~hm~ and *crtI*~ha~). To investigate whether CrtB was still the rate-limiting enzyme in 50BI6, another copy of *crtB* from *H. hispanica* or *H. salinarum* was introduced into 50BI6. We constructed two types of *crtB*-*crtI* expression cassettes, *crtB~ha~-crtI*~ha~ and *crtB~hs~-crtI*~ha~ (Figure [5B](#F5){ref-type="fig"}) and inserted these expression cassettes in the chromosome of 50crtB by replacing *HFX_2549* to obtain new strains, 50B6I6 and 50BHI6 (Figure [1B](#F1){ref-type="fig"} and Supplementary Figure [S1B](#SM1){ref-type="supplementary-material"}). We analyzed the transcriptional status of *crtB*~ha~, *crtB*~hs~, and *crtI*~ha~ in these two strains and found that all the expected genes were successfully transcribed base on the RT-PCR analysis (Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}). The lycopene yields of 50B6I6 and 50BHI6 were further increased to 68.95 ± 1.19 mg/g DCW (353.06 ± 2.39 mg/L) and 60.33 ± 1.56 mg/g DCW (297.05 ± 6.50 mg/L), respectively (Figure [5C](#F5){ref-type="fig"}). This suggested that the strains with co-introduced *crtB*~ha~ and *crtI*~ha~ could produce more lycopene. Lycopene titer displayed a 20.8% increase in 50B6I6 compared to 50BI6.

Disruption of PHBV Biosynthesis to Divert More Acetyl-CoA Flux to Lycopene
--------------------------------------------------------------------------

*H. mediterranei* can accumulate a large amount of PHBV when cultured in MG medium ([@B82]) and acetyl-CoA is an important precursor for its biosynthesis ([@B19]). Blocking acetyl-CoA flux to PHBV biosynthesis may be able to further maximize the lycopene production (Figure [1B](#F1){ref-type="fig"}). To prove this, we knocked out the PHBV synthase encoding genes, *phaE and phaC* ([@B43]), in 50B6I6 and obtained a new strain, named 50B6I6ΔphaEC (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). It could not produce PHBV as determined by gas chromatography (Table [2](#T2){ref-type="table"}) and this result suggested that the deletion of *phaEC* blocked PHBV synthesis. Moreover, HPLC analysis showed that 50B6I6ΔphaEC synthesized lycopene with a production level of 119.25 ± 0.55 mg/g DCW, which was 73.0% higher than that of 50B6I6. Meanwhile, lycopene titer of 50B6I6ΔphaEC increased to 429.41 ± 5.81 mg/L, which was 21% enhancement compared to 50B6I6. This result indicated that the disruption of PHBV biosynthesis could enhance the acetyl-CoA flux to lycopene biosynthesis.

###### 

PHBV content and lycopene production in 50B6I6 and 50B6I6ΔphaEC.

  Strains        PHBV %         Lycopene        
  -------------- -------------- --------------- ---------------
  50B6I6         62.84 ± 1.11   353.06 ± 2.39   68.95 ± 1.19
  50B6I6ΔphaEC   0              429.41 ± 5.81   119.25 ± 0.55

Effect of Auxotrophy on Lycopene Production
-------------------------------------------

In this work, all the genetic manipulation was based on the *pyrF*-deleted strain DF50Δeps (uracil auxotrophic mutant). Uracil addition was required to culture these engineered strains in MG medium. However, this approach was not suitable for high-cell density fermentation and increased the production cost. To address this issue, we restored the functional expression of *pyrF* in 50B6I6ΔphaEC. A linear DNA fragment containing *pyrF* and homologous arms, 500 bp in up-stream or down-stream of *pyrF*, was amplified by PCR using the genomic DNA of *H. mediterranei* as a template and transferred into the 50B6I6ΔphaEC strain. The screening process was carried out using AS-168SY medium, in which the negative colonies could not grow. We obtained the correct *pyrF* complementary strain 50FB6I6ΔphaEC and it gave a lycopene yield of 107.37 ± 2.37 mg/g DCW (396.70 ± 13.39 mg/L), while there was no difference in biomass between 50B6I6ΔphaEC and 50FB6I6ΔphaEC (Figure [6](#F6){ref-type="fig"}). Although the complementation of *pyrF* did not increase the biomass and led to a little decrease in lycopene content, 50FB6I6ΔphaEC could be cultured in MG medium without uracil, which was more feasible for industrial application.

![Dry cell weights of engineered *H. mediterranei* strains.](fmicb-09-02893-g006){#F6}

Discussion
==========

Regarding to food safety issues, lycopene from natural source, such as watermelon, gac fruit, tomato, and so on ([@B57]; [@B72]; [@B44]; [@B53]; [@B76]), is superior to that from chemical synthesis. Among these fruits or vegetables, tomato is a major source of lycopene, but its total lycopene content is too low to meet the market requirements. Multiple strategies of engineering the carotenoid synthesis pathway in tomato fruit to improve its lycopene content were adopted in several studies. [@B23] introduced an additional *crtB* from *Erwinia uredovora* into tomato in a fruit-specific manner and obtained a 1.8-fold increase of lycopene content. [@B20] got a 1.6-fold increase of lycopene content by overexpression of a bacterial 1-deoxy-[D]{.smallcaps}-xylulose-5-phosphate synthase (DXS) encoding gene. [@B48] introduced a bacterial *crtY* gene from *Pantoea agglomerans* into tomato fruit to enhance lycopene production by 2.1-fold. In addition, other strategies were also used to alter carotenoid content in tomato fruit. Overexpression of blue light photoreceptor, cryptochrome 2, resulted in a 1.7-fold increase of lycopene content in tomato fruit ([@B25]). Importing the pepper fibrillin gene into tomato fruit led to a 118% increase in lycopene level ([@B64]). Additionally, [@B47] demonstrated that higher level of polyamines in tomato fruit by fruit-specific overexpression of a yeast *S*-adenosylmethionine decarboxylase gene (*ySAMdc*) enhanced the lycopene content by 2 ∼ 3 folds in tomato fruit. In the same way, [@B50] overexpressed the spermidine synthase gene in tomato and also got an unexpected increase of 1.3 ∼ 2.2 folds in lycopene prodcution. The increased polyamines were revealed to affect multiple cell pathways and broad gene expression levels, thereby enhancing lycopene accumulation ([@B46], [@B45]; [@B35]; [@B36]; [@B50]; [@B27]). However, these transgenic plants are still far from large-scale industrial application for lycopene production (Table [3](#T3){ref-type="table"}). Lycopene production by microbial fermentation is an attractive alternative to use of plants. Moreover, the strains also need to be engineered for improving its production to make the fermentation process more cost competitive. In engineered *E. coli*, the highest lycopene production of 448 mg/g DCW was obtained by employing a new combinatorial multi-gene pathway assembly scheme ([@B17]). In yeast, through engineering host and pathway, the highest lycopene yield, 55.56 mg/g DCW was achieved in 5-L bioreactors ([@B14]). In *B. trispora*, a lycopene production of 103.58 mg/g DCW was realized by the modification of the bifunctional gene, *carRA*, combined with addition of tripropylamine ([@B74]). In this study, a carotenogenic haloarchaea, *H. mediterranei* was chosen as a novel chassis cell for lycopene overproduction, due to its several superior features, such as high salt tolerance capability, easy lysis, etc. These can contribute to reduce the energy cost brought by strict sterilization and to simplify the process for lycopene extraction. We adopted multiple strategies to engineer *H. mediterranei* for lycopene production enhancement and finally our best strain gave a lycopene yield of 119.25 mg/g DCW, which was even higher than the yields of most well-studied strains (Table [3](#T3){ref-type="table"}). Although engineered *E. coli* produced the highest level of lycopene, it is controversial to use it for lycopene synthesis, since this strain would release endotoxin ([@B59]). In contrast, haloarchaea has an extremely low endotoxin level because of its special structure of cell envelope ([@B81]). Thus, *H. mediterranei* is a promising microbial host for lycopene biosynthesis.

###### 

Summary of lycopene production in transgenic plant and engineered microorganisms.

  Organism                Strategies                                                       Culture condition               Lycopene production   Reference
  ----------------------- ---------------------------------------------------------------- ------------------------------- --------------------- ------------
  **Plant**                                                                                                                                      
  Tomato                  Engineering carotenoids synthesis pathway                        Grown in the glasshouse         5.22 mg/g DCW         [@B23]
  Tomato                                                                                   Grown in the glasshouse         6.7 mg/g DCW          [@B20]
  Tomato                                                                                   Grown in green house            ∼0.11 mg/g DCW        [@B48]
  Tomato                  Manipulation of the blue light photoreceptor cryptochrome 2      Grown in green house            1.35 mg/g DCW         [@B25]
  Tomato                  Importing the pepper fibrillin gene in tomato                    Grown in green house            ∼0.48 mg/g FW^∗^      [@B64]
  Tomato                  Enhancement of polyamine accumulation                            Grown in green house            ∼0.11 mg/g FW^∗^      [@B47]
  Tomato                                                                                   Grown in green house            1.72 mg/g DCW         [@B50]
  **Microbe**                                                                                                                                    
  50B6I6ΔphaEC            Pathway engineering                                              Shake flask fermentation        119.25 mg/g DCW       This study
  *E. coli*                                                                                Microtiter plate fermentation   448 mg/g DCW          [@B17]
  *E. coli*               Chromosomal evolution                                            Shake flask fermentation        33.4 mg/g DCW         [@B15]
  *E. coli*               Pathway balancing                                                Fed-batch fermentation          43.7 mg/g DCW         [@B83]
  *E. coli*               Pathway engineering combined with NADPH and ATP balancing        Fed-batch fermentation          50.6 mg/g DCW         [@B69])
  *E. coli*               Plasmid based overexpression of carotenoids synthesis genes      Shake flask fermentation        67 mg/g DCW           [@B80]
  *S. cerevisiae*         Directed evolution and metabolic engineering                     Fed-batch fermentation          24.41 mg/g DCW        [@B78]
  *S. cerevisiae*         Pathway engineering                                              Fed-batch fermentation          55.56 mg/g DCW        [@B14]
  *Yarrowia lipolytica*                                                                    Fed-batch fermentation          21.1 mg/g DCW         [@B62]
  *B. trispora*           Genetically manipulated the bifunctional protein gene, *carRA*   Shake flask fermentation        103.58 mg/g DCW       [@B74]

∗

FW, fresh weight.

However, in optimal culture conditions for growth, *H. mediterranei*, is less pigmented and no lycopene can be detected (Figure [3B](#F3){ref-type="fig"}). This might be due to the presence of a rate-limiting step involved in lycopene synthesis. Then we investigated the overexpression of the possible rate-limiting enzyme encoding genes in the MVA and lycopene synthesis pathway and found that only *crtB* overexpression resulted in significant lycopene accumulation. This result suggested that the MVA pathway in *H. mediterranei* is efficient to produce essential precursors of IPP and DMAPP for lycopene synthesis. Thus, in the next step, the first strategy we adopted to improve lycopene production was reinforcing lycopene synthesis pathway. First, we eliminated the rate-limiting step by inserting a strong promoter in the chromosome ahead of *crtB* and realized a lycopene production of 6.05 mg/g DCW. Then to avoid the limitation of final target products, brought by insufficient ability of downstream pathway ([@B38]), we imported heterologous *crtI* and enhanced the lycopene production to 56.46 mg/g DCW. Next, we integrated heterologous haloarchaeal *crtB-crtI cassettes* into the chromosome and got a lycopene yield of 68.95 mg/g DCW. Similarly, [@B78] adjusted the copy number of *crt* genes to get more than 80% increase of lycopene production in *Saccharomyces cerevisiae*. They reported that multiple copies of *crt* genes led to an about 13% decrease in biomass ([@B78]). Similar results were also obtained in the present study (Figure [6](#F6){ref-type="fig"}). The dry cell weight of the engineered strains 50BI6, 50BIH, 50B6I6, and 50BHI6 showed a decrease of about 10%. This might be due to the metabolic burden brought by the overexpression of *crt* genes. However, the significant increase of lycopene titer overweighed the slight biomass decrease in these engineered strains.

The second strategy we used is disruption of the lycopene flux to other carotenoids or deletion of the competing pathways sharing common precursors with the lycopene synthetic pathway. [@B73] inhibited the activity of lycopene cyclase, the enzyme responsible for conversion of lycopene to β-carotene, and increased the lycopene content by 90.1%. In *E. coli*, the knockout of *gdhA*, *accE*, and *fdhF* gave a 37% increase in lycopene content ([@B1]). In this work, we knocked out the gene *lyeJ* to block the bacterioruberin biosynthesis and thus improved the lycopene purity and got a 6.5-fold increase of lycopene production. MVA pathway commences with acetyl-CoA, which is also the important precursor for PHBV synthesis in *H. mediterranei*. Removing the competing pathways for lycopene synthesis can theoretically facilitate lycopene accumulation. So we disrupted the PHBV synthesis in *H. mediterranei*, by deleting the key genes *phaE* and *phaC*. As expected, the engineered strain 50B6I6ΔphaEC did not synthesis PHBV and showed an increase of lycopene titer as expected. The loss of PHBV caused a decrease in dry cell weight by 42% (Figure [6](#F6){ref-type="fig"}). On the other hand, the lycopene production was sharply enhanced by 73%. This indicated that more acetyl-CoA could flux to lycopene synthesis *via* MVA pathway with the disruption of PHBV synthesis.

High biomass is necessary to achieve a high yield of lycopene. However, the presence of auxotrophies can cause an organism to grow more slowly than the equivalent prototroph ([@B58]). Furthermore, it is not feasible for high-cell density fermentation and practical application because of the requirement of additional uracil. In *Y. lipolytica*, the alleviation of both *leu2* and *ura3* auxotrophies gave a 1.9-fold enhancement in lycopene titer ([@B62]). In this work, we complemented the *pyrF* auxotrophy in strain 50B6I6ΔphaEC. The engineered strain 50FB6I6ΔphaEC showed no difference in dry cell weight compared with 50B6I6ΔphaEC (Figure [6](#F6){ref-type="fig"}), but gave a little decrease in lycopene titer and production. The low lycopene accumulation after the complementation of *pyrF* gene might be ascribed to the fact that the utilization efficiency of the uracil synthesized *in vivo* was lower than that of the uracil added for cell growth. However, no need for uracil overweighed the slight decrease of lycopene production as for developing a cost-effective industrial strain.

This work reveals that *H. mediterranei* possesses a great potential for lycopene biosynthesis and much more efforts are needed to further increase its lycopene production. The reduction of FPP flux to the squalene biosynthetic pathway (a competing pathway for carotenoid synthesis) is expected to further increase lycopene yield. This strategy has been used to improve lycopene production in yeast ([@B79]). Besides, modulation of the NADPH and ATP levels is another alternative approach for further enhancing lycopene synthesis in *H. mediterranei*. Additionally, optimization of culture conditions and fed-batch fermentation might also be adopted for maximizing lycopene production in *H. mediterranei*.

Conclusion
==========

In this work, we engineered a haloarchaeon, *H. mediterranei*, as a novel host for lycopene overproduction by adopting multiple strategies. Introducing a constitutive promoter enhanced the expression level of the rate-limiting enzyme encoding gene, *crtB*, and disrupting the bacterioruberin synthesis significantly increased the lycopene production and purity. Importing different heterologous *crt* expression cassettes were also an effective method for improving lycopene production. Further blocking PHBV synthesis to direct more acetyl-CoA flux into carotenoid synthesis showed a dramatic increase in lycopene production, up to 119.25 ± 0.55 mg/g DCW, in shake flask fermentation. Complementation of *pyrF* in the engineered strain 50B6I6ΔphaEC had no increase in both dry cell weight and lycopene production, but it could grow without addition of uracil and thus is more suitable for industrial application. The engineering pathway that we developed in this study shows the potential for high-level production of lycopene and offers biological insights into carotenoid production in haloarchaea.
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